An Age-Old Question

Age-old Question(naire)s

Older people are an important and growing sector of the population, yet are often excluded by design. It is important to find out more about this user group so that they can be included effectively. As a first step towards this, we carried out a questionnaire and interview study in Scotland with 353 participants over the age of 50, investigating their use of and attitude towards technology. Thi...

An age old question: does size really matter?

See related article, pages 307–312. The Intensive Blood Pressure Reduction In Acute Cerebral Hemorrhage Trial (INTERACT) trial suggests that early, intensive blood pressure (BP) lowering can attenuate hematoma extension or growth (HE) 24 hours after intracerebral hemorrhage (ICH).1 The primary goal of this more detailed analysis published in this issue of Stroke2 is to determine if the BP-lower...

Surgeon Experience and Outcomes: An Age Old Question.

Busulfan or TBI: answer to an age-old question.

In this issue of Blood, authors of 2 articles have compared busulfan with total body irradiation (TBI) in preparative regimens for hematopoietic transplantation as treatment of acute myeloid leukemia (AML).

The age old question: who benefits from prostate cancer treatment?

Active surveillance and watchful waiting are potential alternatives to delay or avoid the need for treatment in carefully selected patients. The key issue is determining which patients are appropriate for conservative management. Although these approaches are often targeted toward elderly men, such men are more likely to be diagnosed with high-risk disease. A recent study by Scosyrev et al. [2]...